

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 6.75272566 |
| 2 | intestinal absorption (GO:0050892) | 6.35595721 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.05485702 |
| 4 | cellular glucuronidation (GO:0052695) | 5.87338252 |
| 5 | angiotensin maturation (GO:0002003) | 5.77221623 |
| 6 | sulfate transmembrane transport (GO:1902358) | 5.73702476 |
| 7 | uronic acid metabolic process (GO:0006063) | 5.65515591 |
| 8 | glucuronate metabolic process (GO:0019585) | 5.65515591 |
| 9 | flavonoid metabolic process (GO:0009812) | 5.12405959 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 5.11885272 |
| 11 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.94712898 |
| 12 | bile acid and bile salt transport (GO:0015721) | 4.93425231 |
| 13 | renal system process involved in regulation of blood volume (GO:0001977) | 4.89420792 |
| 14 | positive regulation of respiratory burst (GO:0060267) | 4.87954896 |
| 15 | oligosaccharide biosynthetic process (GO:0009312) | 4.82194423 |
| 16 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.77953063 |
| 17 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.77953063 |
| 18 | endocrine process (GO:0050886) | 4.77953063 |
| 19 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.77104943 |
| 20 | ethanol oxidation (GO:0006069) | 4.74774046 |
| 21 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.71162925 |
| 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.70345924 |
| 23 | sulfate transport (GO:0008272) | 4.65778624 |
| 24 | O-glycan processing (GO:0016266) | 4.47509757 |
| 25 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.46184066 |
| 26 | NADH metabolic process (GO:0006734) | 4.45255871 |
| 27 | sperm capacitation (GO:0048240) | 4.27581074 |
| 28 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.24489816 |
| 29 | regulation of vitamin metabolic process (GO:0030656) | 4.20727771 |
| 30 | regulation of systemic arterial blood pressure (GO:0003073) | 4.13928065 |
| 31 | regulation of cGMP biosynthetic process (GO:0030826) | 4.10170839 |
| 32 | nucleoside diphosphate biosynthetic process (GO:0009133) | 4.04949825 |
| 33 | glomerular filtration (GO:0003094) | 4.02057562 |
| 34 | regulation of bile acid biosynthetic process (GO:0070857) | 3.99187677 |
| 35 | ethanol metabolic process (GO:0006067) | 3.98090520 |
| 36 | glucocorticoid biosynthetic process (GO:0006704) | 3.89114446 |
| 37 | positive regulation of pseudopodium assembly (GO:0031274) | 3.87064178 |
| 38 | regulation of cellular extravasation (GO:0002691) | 3.85532885 |
| 39 | desmosome organization (GO:0002934) | 3.84709341 |
| 40 | drug metabolic process (GO:0017144) | 3.83487816 |
| 41 | transcytosis (GO:0045056) | 3.82791722 |
| 42 | diacylglycerol metabolic process (GO:0046339) | 3.74207206 |
| 43 | regulation of respiratory burst (GO:0060263) | 3.67875538 |
| 44 | antimicrobial humoral response (GO:0019730) | 3.67759730 |
| 45 | digestive system process (GO:0022600) | 3.64995166 |
| 46 | renal filtration (GO:0097205) | 3.63754328 |
| 47 | cGMP-mediated signaling (GO:0019934) | 3.63585295 |
| 48 | digestion (GO:0007586) | 3.61191234 |
| 49 | bicarbonate transport (GO:0015701) | 3.60850133 |
| 50 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.56555969 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56305360 |
| 52 | antibacterial humoral response (GO:0019731) | 3.54177251 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.53198611 |
| 54 | receptor recycling (GO:0001881) | 3.52988617 |
| 55 | lipoprotein transport (GO:0042953) | 3.51348389 |
| 56 | excretion (GO:0007588) | 3.48785764 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 3.47380724 |
| 58 | intestinal epithelial cell development (GO:0060576) | 3.45841957 |
| 59 | regulation of pseudopodium assembly (GO:0031272) | 3.44084331 |
| 60 | sodium ion homeostasis (GO:0055078) | 3.41276068 |
| 61 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.33934393 |
| 62 | regulation of cGMP metabolic process (GO:0030823) | 3.33651289 |
| 63 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.30760351 |
| 64 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.30760351 |
| 65 | cellular response to pH (GO:0071467) | 3.29050878 |
| 66 | sulfur compound transport (GO:0072348) | 3.28237706 |
| 67 | hormone catabolic process (GO:0042447) | 3.27343022 |
| 68 | vitamin transmembrane transport (GO:0035461) | 3.23752021 |
| 69 | drug transmembrane transport (GO:0006855) | 3.23301795 |
| 70 | epithelial structure maintenance (GO:0010669) | 3.20382467 |
| 71 | urea cycle (GO:0000050) | 3.16986206 |
| 72 | phenylpropanoid metabolic process (GO:0009698) | 3.16700014 |
| 73 | multicellular organismal water homeostasis (GO:0050891) | 3.10446062 |
| 74 | sphingomyelin metabolic process (GO:0006684) | 3.05076988 |
| 75 | auditory receptor cell differentiation (GO:0042491) | 3.03293158 |
| 76 | urea metabolic process (GO:0019627) | 3.02841654 |
| 77 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.98728376 |
| 78 | drug transport (GO:0015893) | 2.97977094 |
| 79 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.97036968 |
| 80 | thrombin receptor signaling pathway (GO:0070493) | 2.96550127 |
| 81 | actin filament depolymerization (GO:0030042) | 2.94207981 |
| 82 | cGMP biosynthetic process (GO:0006182) | 2.93195083 |
| 83 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.92589950 |
| 84 | positive regulation of fatty acid oxidation (GO:0046321) | 2.90478256 |
| 85 | sexual reproduction (GO:0019953) | 2.90349454 |
| 86 | GDP-mannose metabolic process (GO:0019673) | 2.89863109 |
| 87 | drug catabolic process (GO:0042737) | 2.86668160 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 2.86667805 |
| 89 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.85100946 |
| 90 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.84758610 |
| 91 | amino-acid betaine transport (GO:0015838) | 2.84607581 |
| 92 | carnitine transport (GO:0015879) | 2.84607581 |
| 93 | COPII vesicle coating (GO:0048208) | 2.83628163 |
| 94 | regulation of protein glycosylation (GO:0060049) | 2.83468757 |
| 95 | vitamin transport (GO:0051180) | 2.82171433 |
| 96 | labyrinthine layer development (GO:0060711) | 2.82078930 |
| 97 | exogenous drug catabolic process (GO:0042738) | 2.81450612 |
| 98 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.80919377 |
| 99 | fructose metabolic process (GO:0006000) | 2.78140218 |
| 100 | monovalent inorganic cation homeostasis (GO:0055067) | 2.76245327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.17529780 |
| 2 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.33284706 |
| 3 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.93341338 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88521719 |
| 5 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.80744361 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.79157876 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.72214489 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.68080560 |
| 9 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.58786130 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.45058031 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32657311 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31120132 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.21604685 |
| 14 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.21555923 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15282133 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.15233105 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.13356537 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12605732 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.12287545 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07698486 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07150357 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02723356 |
| 23 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.92596709 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86313913 |
| 25 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.82866758 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82421718 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.81769820 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.78501746 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.78152127 |
| 30 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.76713521 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75440962 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73928434 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67671141 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62439064 |
| 35 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.60207995 |
| 36 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.58468211 |
| 37 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.58355862 |
| 38 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.57726324 |
| 39 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.57472761 |
| 40 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55630070 |
| 41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48626154 |
| 42 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.47824854 |
| 43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47756562 |
| 44 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.44051245 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42142617 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39735112 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.38525513 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38175024 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35198085 |
| 50 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.31302357 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30845143 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28696257 |
| 53 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.26210043 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26144621 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24932291 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24394884 |
| 57 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17663691 |
| 58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13075409 |
| 59 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12555074 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11904722 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07942602 |
| 62 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.04334208 |
| 63 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04074092 |
| 64 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02659655 |
| 65 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01936660 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98968088 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98929590 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98609285 |
| 69 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97479263 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95891808 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95478960 |
| 72 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94130348 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92782370 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92066809 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90906431 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90879697 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90592362 |
| 78 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90573066 |
| 79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88517570 |
| 80 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88054217 |
| 81 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87713142 |
| 82 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.86856824 |
| 83 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86708447 |
| 84 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85946485 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85548340 |
| 86 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.84488875 |
| 87 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.83898849 |
| 88 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83604959 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82829245 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82114111 |
| 91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81113876 |
| 92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79876133 |
| 93 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.78678935 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77539997 |
| 95 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.77512742 |
| 96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.77318515 |
| 97 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.76776755 |
| 98 | CJUN_26792858_Chip-Seq_BT549_Human | 0.76078913 |
| 99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75785202 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75522534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.74906848 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.59956960 |
| 3 | MP0005360_urolithiasis | 4.40715587 |
| 4 | MP0008004_abnormal_stomach_pH | 3.82738480 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.76119400 |
| 6 | MP0004264_abnormal_extraembryonic_tissu | 3.55948447 |
| 7 | MP0005365_abnormal_bile_salt | 3.42338433 |
| 8 | MP0001664_abnormal_digestion | 3.26157649 |
| 9 | MP0004043_abnormal_pH_regulation | 3.15637597 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.12918313 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.98137202 |
| 12 | MP0003866_abnormal_defecation | 2.80623630 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.66538604 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.55976824 |
| 15 | MP0003868_abnormal_feces_composition | 2.52711442 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.45490561 |
| 17 | MP0001765_abnormal_ion_homeostasis | 2.29105091 |
| 18 | MP0000490_abnormal_crypts_of | 2.26741392 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.14852954 |
| 20 | MP0001873_stomach_inflammation | 2.08477668 |
| 21 | MP0001663_abnormal_digestive_system | 2.06309344 |
| 22 | MP0000477_abnormal_intestine_morphology | 2.06110231 |
| 23 | MP0004147_increased_porphyrin_level | 2.02585850 |
| 24 | MP0005670_abnormal_white_adipose | 2.02124890 |
| 25 | MP0002796_impaired_skin_barrier | 2.00116173 |
| 26 | MP0005381_digestive/alimentary_phenotyp | 1.89560887 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.81163080 |
| 28 | MP0005409_darkened_coat_color | 1.73820448 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 1.73222838 |
| 30 | MP0000462_abnormal_digestive_system | 1.62744678 |
| 31 | MP0003252_abnormal_bile_duct | 1.55744262 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.51152625 |
| 33 | MP0005166_decreased_susceptibility_to | 1.49725204 |
| 34 | MP0005451_abnormal_body_composition | 1.48122113 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.47998771 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.43292026 |
| 37 | MP0009840_abnormal_foam_cell | 1.39122077 |
| 38 | MP0003879_abnormal_hair_cell | 1.38145334 |
| 39 | MP0005501_abnormal_skin_physiology | 1.32847877 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.29361384 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.28591668 |
| 42 | MP0000566_synostosis | 1.28508931 |
| 43 | MP0002098_abnormal_vibrissa_morphology | 1.27404636 |
| 44 | MP0001756_abnormal_urination | 1.24599891 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.22635168 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21482787 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.20862745 |
| 48 | MP0000470_abnormal_stomach_morphology | 1.20150780 |
| 49 | MP0002136_abnormal_kidney_physiology | 1.18043966 |
| 50 | MP0002009_preneoplasia | 1.15585591 |
| 51 | MP0005310_abnormal_salivary_gland | 1.13827168 |
| 52 | MP0005332_abnormal_amino_acid | 1.13590549 |
| 53 | MP0000537_abnormal_urethra_morphology | 1.12274160 |
| 54 | MP0000230_abnormal_systemic_arterial | 1.08491871 |
| 55 | MP0001188_hyperpigmentation | 1.08222929 |
| 56 | MP0010678_abnormal_skin_adnexa | 1.02622896 |
| 57 | MP0005666_abnormal_adipose_tissue | 0.99739944 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 0.98958819 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 0.98874198 |
| 60 | MP0002166_altered_tumor_susceptibility | 0.98169547 |
| 61 | MP0001764_abnormal_homeostasis | 0.92795478 |
| 62 | MP0002971_abnormal_brown_adipose | 0.89317136 |
| 63 | MP0001849_ear_inflammation | 0.88303610 |
| 64 | MP0005165_increased_susceptibility_to | 0.86506261 |
| 65 | MP0000467_abnormal_esophagus_morphology | 0.86264514 |
| 66 | MP0009115_abnormal_fat_cell | 0.84591094 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 0.83329949 |
| 68 | MP0001485_abnormal_pinna_reflex | 0.82311826 |
| 69 | MP0001501_abnormal_sleep_pattern | 0.82163500 |
| 70 | MP0000538_abnormal_urinary_bladder | 0.77836432 |
| 71 | MP0003724_increased_susceptibility_to | 0.77791863 |
| 72 | MP0000609_abnormal_liver_physiology | 0.77783853 |
| 73 | MP0004858_abnormal_nervous_system | 0.76602116 |
| 74 | MP0005448_abnormal_energy_balance | 0.75791816 |
| 75 | MP0000516_abnormal_urinary_system | 0.75577516 |
| 76 | MP0005367_renal/urinary_system_phenotyp | 0.75577516 |
| 77 | MP0003300_gastrointestinal_ulcer | 0.74506827 |
| 78 | MP0003283_abnormal_digestive_organ | 0.73934209 |
| 79 | MP0001216_abnormal_epidermal_layer | 0.69816005 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.68735339 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68260519 |
| 82 | MP0008872_abnormal_physiological_respon | 0.67351159 |
| 83 | MP0001845_abnormal_inflammatory_respons | 0.62637301 |
| 84 | MP0002006_tumorigenesis | 0.62077625 |
| 85 | MP0003953_abnormal_hormone_level | 0.60980971 |
| 86 | MP0004947_skin_inflammation | 0.58309084 |
| 87 | MP0002896_abnormal_bone_mineralization | 0.58080104 |
| 88 | MP0009642_abnormal_blood_homeostasis | 0.56545098 |
| 89 | MP0000377_abnormal_hair_follicle | 0.54270181 |
| 90 | MP0009785_altered_susceptibility_to | 0.53638910 |
| 91 | MP0003315_abnormal_perineum_morphology | 0.53197661 |
| 92 | MP0002132_abnormal_respiratory_system | 0.51490590 |
| 93 | MP0005535_abnormal_body_temperature | 0.51191474 |
| 94 | MP0004484_altered_response_of | 0.51167470 |
| 95 | MP0003045_fibrosis | 0.48688334 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.48510555 |
| 97 | MP0005275_abnormal_skin_tensile | 0.48322768 |
| 98 | MP0000681_abnormal_thyroid_gland | 0.46789021 |
| 99 | MP0003303_peritoneal_inflammation | 0.46274185 |
| 100 | MP0003693_abnormal_embryo_hatching | 0.45267131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 9.21623370 |
| 2 | Decreased circulating renin level (HP:0003351) | 6.84767425 |
| 3 | Metabolic alkalosis (HP:0200114) | 6.61198667 |
| 4 | Abnormality of renin-angiotensin system (HP:0000847) | 6.31507706 |
| 5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.60472479 |
| 6 | Abnormality of chloride homeostasis (HP:0011422) | 4.96312080 |
| 7 | Alkalosis (HP:0001948) | 4.80754190 |
| 8 | Malnutrition (HP:0004395) | 4.70214958 |
| 9 | Hyperaldosteronism (HP:0000859) | 4.65369351 |
| 10 | Flat acetabular roof (HP:0003180) | 4.55050243 |
| 11 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.53181062 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 4.46331672 |
| 13 | Abnormality of vitamin B metabolism (HP:0004340) | 4.35527873 |
| 14 | Ileus (HP:0002595) | 3.96175739 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.93484446 |
| 16 | Hyponatremia (HP:0002902) | 3.87122697 |
| 17 | Abnormality of vitamin metabolism (HP:0100508) | 3.75999336 |
| 18 | Abdominal distention (HP:0003270) | 3.67240926 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 3.51943406 |
| 20 | Hydroxyprolinuria (HP:0003080) | 3.44542839 |
| 21 | Abnormality of proline metabolism (HP:0010907) | 3.44542839 |
| 22 | Hypokalemia (HP:0002900) | 3.40773426 |
| 23 | Hyperkalemia (HP:0002153) | 3.40242618 |
| 24 | Abnormality of potassium homeostasis (HP:0011042) | 3.33156344 |
| 25 | Fat malabsorption (HP:0002630) | 3.26929290 |
| 26 | Congenital sensorineural hearing impairment (HP:0008527) | 3.26373015 |
| 27 | Chronic diarrhea (HP:0002028) | 3.17858012 |
| 28 | Villous atrophy (HP:0011473) | 3.16260457 |
| 29 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.16260457 |
| 30 | Hemorrhage of the eye (HP:0011885) | 3.08860040 |
| 31 | Flattened epiphyses (HP:0003071) | 2.93270373 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93176156 |
| 33 | Abnormality of sodium homeostasis (HP:0010931) | 2.91006569 |
| 34 | Abnormal tarsal ossification (HP:0008369) | 2.86447143 |
| 35 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.83726347 |
| 36 | Hyperparathyroidism (HP:0000843) | 2.80611006 |
| 37 | Widely patent fontanelles and sutures (HP:0004492) | 2.78121565 |
| 38 | Adrenal overactivity (HP:0002717) | 2.70694501 |
| 39 | Dehydration (HP:0001944) | 2.67308533 |
| 40 | Focal segmental glomerulosclerosis (HP:0000097) | 2.65313682 |
| 41 | Neonatal short-limb short stature (HP:0008921) | 2.64974188 |
| 42 | Pili torti (HP:0003777) | 2.64961838 |
| 43 | Hypotension (HP:0002615) | 2.58873459 |
| 44 | Hyperammonemia (HP:0001987) | 2.54091358 |
| 45 | Thin bony cortex (HP:0002753) | 2.52827017 |
| 46 | Abnormal biliary tract morphology (HP:0012440) | 2.48701248 |
| 47 | Syncope (HP:0001279) | 2.48580171 |
| 48 | Acanthocytosis (HP:0001927) | 2.47457069 |
| 49 | Chronic bronchitis (HP:0004469) | 2.46981133 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.45067480 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40947060 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.40947060 |
| 53 | Megaloblastic anemia (HP:0001889) | 2.38490997 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.37070598 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.35454528 |
| 56 | Hyperuricemia (HP:0002149) | 2.34771002 |
| 57 | Increased purine levels (HP:0004368) | 2.34771002 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.33587190 |
| 59 | Glomerulosclerosis (HP:0000096) | 2.28031857 |
| 60 | Pigmentary retinal degeneration (HP:0001146) | 2.25632490 |
| 61 | Visceral angiomatosis (HP:0100761) | 2.24768060 |
| 62 | Flat capital femoral epiphysis (HP:0003370) | 2.18324985 |
| 63 | Glycosuria (HP:0003076) | 2.18075276 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.18075276 |
| 65 | Confusion (HP:0001289) | 2.11552768 |
| 66 | Abnormality of carpal bone ossification (HP:0006257) | 2.10527754 |
| 67 | Wide cranial sutures (HP:0010537) | 2.08516196 |
| 68 | Renal tubular acidosis (HP:0001947) | 2.06100436 |
| 69 | Abnormal hair laboratory examination (HP:0003328) | 2.04880448 |
| 70 | Renal salt wasting (HP:0000127) | 2.01990357 |
| 71 | Symptomatic seizures (HP:0011145) | 2.01534274 |
| 72 | Spinal cord compression (HP:0002176) | 1.99187359 |
| 73 | Hypobetalipoproteinemia (HP:0003563) | 1.97525851 |
| 74 | Curly hair (HP:0002212) | 1.97419592 |
| 75 | Cone-rod dystrophy (HP:0000548) | 1.92445075 |
| 76 | Nasal polyposis (HP:0100582) | 1.91520009 |
| 77 | Hemangiomatosis (HP:0007461) | 1.91326836 |
| 78 | Metabolic acidosis (HP:0001942) | 1.90958535 |
| 79 | Abnormality of purine metabolism (HP:0004352) | 1.90498408 |
| 80 | Growth hormone excess (HP:0000845) | 1.87674355 |
| 81 | Palpitations (HP:0001962) | 1.87548057 |
| 82 | Hyperphosphatemia (HP:0002905) | 1.87523020 |
| 83 | Gout (HP:0001997) | 1.87300980 |
| 84 | Protuberant abdomen (HP:0001538) | 1.86873691 |
| 85 | Proximal tubulopathy (HP:0000114) | 1.86712328 |
| 86 | Late onset (HP:0003584) | 1.84938265 |
| 87 | Subcapsular cataract (HP:0000523) | 1.84749628 |
| 88 | Ankle clonus (HP:0011448) | 1.79978567 |
| 89 | Cerebral palsy (HP:0100021) | 1.77864196 |
| 90 | Abnormality of the costochondral junction (HP:0000919) | 1.76726846 |
| 91 | Nephrolithiasis (HP:0000787) | 1.75719000 |
| 92 | Abnormal hand bone ossification (HP:0010660) | 1.75668210 |
| 93 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73983337 |
| 94 | Abnormal foot bone ossification (HP:0010675) | 1.71724667 |
| 95 | Xanthomatosis (HP:0000991) | 1.71295417 |
| 96 | Amelogenesis imperfecta (HP:0000705) | 1.70647069 |
| 97 | Enlarged epiphyses (HP:0010580) | 1.69792976 |
| 98 | Abnormality of the 1st metacarpal (HP:0010009) | 1.68517991 |
| 99 | Vertebral clefting (HP:0008428) | 1.68307989 |
| 100 | Abnormal ossification of hand bones (HP:0005921) | 1.64342713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.03791817 |
| 2 | EPHA2 | 5.26865898 |
| 3 | ACVR1B | 5.08199857 |
| 4 | PIK3CA | 4.63054261 |
| 5 | RIPK1 | 4.41220979 |
| 6 | LMTK2 | 3.51331428 |
| 7 | ERN1 | 2.92804659 |
| 8 | STK39 | 2.78924745 |
| 9 | PRKG2 | 2.65241757 |
| 10 | MAP3K10 | 2.55139182 |
| 11 | EPHA3 | 2.26498534 |
| 12 | MET | 2.25404272 |
| 13 | EPHB2 | 2.16612280 |
| 14 | MAP3K2 | 1.79267683 |
| 15 | OXSR1 | 1.75742498 |
| 16 | MYLK | 1.65093605 |
| 17 | PTK6 | 1.60564461 |
| 18 | FGFR4 | 1.48322785 |
| 19 | TESK1 | 1.47482006 |
| 20 | MST4 | 1.36047805 |
| 21 | EPHB1 | 1.34062037 |
| 22 | STK24 | 1.30858626 |
| 23 | MAP3K12 | 1.27478116 |
| 24 | PIK3CG | 1.23075456 |
| 25 | FGFR3 | 1.10761202 |
| 26 | MAP3K1 | 1.05062539 |
| 27 | NEK1 | 1.03869170 |
| 28 | FER | 0.99941495 |
| 29 | PDPK1 | 0.98328041 |
| 30 | DDR2 | 0.93358586 |
| 31 | MAP2K2 | 0.92661854 |
| 32 | AKT3 | 0.88362811 |
| 33 | TAOK1 | 0.85392756 |
| 34 | DYRK1B | 0.84221645 |
| 35 | PIM2 | 0.82210939 |
| 36 | WNK4 | 0.81633771 |
| 37 | PINK1 | 0.80281536 |
| 38 | NLK | 0.76371342 |
| 39 | TESK2 | 0.75772434 |
| 40 | INSRR | 0.70832504 |
| 41 | PRKAA2 | 0.69138268 |
| 42 | PDK1 | 0.66342356 |
| 43 | ERBB2 | 0.66302996 |
| 44 | MATK | 0.65237749 |
| 45 | MAPK15 | 0.64850298 |
| 46 | PRPF4B | 0.63229328 |
| 47 | CAMK2D | 0.61740593 |
| 48 | DMPK | 0.59993913 |
| 49 | MAPK11 | 0.58401247 |
| 50 | GRK6 | 0.58373407 |
| 51 | CDC42BPA | 0.56652500 |
| 52 | IRAK1 | 0.54320377 |
| 53 | TNIK | 0.52562554 |
| 54 | STK38 | 0.52430826 |
| 55 | MAP3K3 | 0.52176308 |
| 56 | LATS1 | 0.51395482 |
| 57 | MAP2K6 | 0.50888721 |
| 58 | PTK2 | 0.50056365 |
| 59 | PDK2 | 0.48883444 |
| 60 | STK38L | 0.47587209 |
| 61 | NME1 | 0.46927235 |
| 62 | TRIB3 | 0.46752996 |
| 63 | PAK4 | 0.44232648 |
| 64 | RPS6KA2 | 0.42847399 |
| 65 | TYK2 | 0.42378942 |
| 66 | KSR2 | 0.39889866 |
| 67 | NEK6 | 0.38890028 |
| 68 | ZAP70 | 0.37836260 |
| 69 | PRKACG | 0.35407790 |
| 70 | PLK4 | 0.35357205 |
| 71 | RET | 0.34410160 |
| 72 | RIPK4 | 0.33142917 |
| 73 | PRKCA | 0.32322823 |
| 74 | ABL2 | 0.31822724 |
| 75 | MAPKAPK2 | 0.31381585 |
| 76 | SGK223 | 0.30721656 |
| 77 | SGK494 | 0.30721656 |
| 78 | MAP2K1 | 0.29817195 |
| 79 | CSNK1A1 | 0.29470431 |
| 80 | SRC | 0.29319637 |
| 81 | MAPKAPK3 | 0.29259741 |
| 82 | SMG1 | 0.29196921 |
| 83 | PRKCI | 0.28551624 |
| 84 | EEF2K | 0.24866958 |
| 85 | RPS6KB1 | 0.23520548 |
| 86 | DAPK3 | 0.21749912 |
| 87 | GRK1 | 0.20309179 |
| 88 | SGK3 | 0.19754536 |
| 89 | PRKCZ | 0.17185045 |
| 90 | CSK | 0.16439525 |
| 91 | JAK2 | 0.15935789 |
| 92 | ROCK1 | 0.15798678 |
| 93 | TBK1 | 0.15678252 |
| 94 | LRRK2 | 0.14163218 |
| 95 | IRAK3 | 0.13344705 |
| 96 | PRKCD | 0.11767127 |
| 97 | MAP3K11 | 0.11450551 |
| 98 | TYRO3 | 0.11301447 |
| 99 | SGK2 | 0.11166728 |
| 100 | CASK | 0.11155115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.92030731 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.91331221 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.28711700 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.23175929 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.91518796 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88062054 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.78889361 |
| 8 | Mineral absorption_Homo sapiens_hsa04978 | 2.74590143 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.65173883 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.63319437 |
| 11 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.43771321 |
| 12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.17918248 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.17915131 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16517107 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.15112399 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 2.13580230 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.11642658 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.06547986 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.05026817 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.98747517 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96503903 |
| 22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.93778420 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82986757 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.74336454 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71956514 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65907867 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49953793 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48509735 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.48344571 |
| 30 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.48265227 |
| 31 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.40891659 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36821421 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32447815 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.27473946 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19610836 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17402135 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09448043 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08808648 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04964183 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03863187 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98916183 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97357699 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96375376 |
| 44 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92432892 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92001781 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86063567 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84276509 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80684250 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78262909 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74072044 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 0.73174935 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69995520 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68041096 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66885368 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60670549 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60614211 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60029870 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59462204 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57962884 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57942213 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57324520 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.56968918 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.55553659 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53136343 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51710637 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51226137 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.50202231 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46268332 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44130197 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.37992824 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37768548 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.34487367 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.28703600 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.28509774 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28224078 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26376680 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.24713031 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.20208592 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17118643 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16071577 |
| 81 | Allograft rejection_Homo sapiens_hsa05330 | 0.14493225 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.13002958 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12068312 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.12040530 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.12011805 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11899132 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.11656963 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.11623069 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11261072 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.09520376 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09213032 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.07816470 |
| 93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.06920982 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.06307168 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.04734181 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.03732653 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03624245 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.01649776 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01392393 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.01390333 |

